Medication Guide App

M O17 (Oxybutynin chloride extended release 15 mg)

Pill imprint M O17 has been identified as Oxybutynin chloride extended release 15 mg.

Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; dysuria; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M O17

Oxybutynin chloride extended release 15 mg M O17  Front
Oxybutynin chloride extended release 15 mg M O17  Back
Oxybutynin chloride extended release 15 mg M O17
Oxybutynin chloride extended release
Imprint:
M O17
Strength:
15 mg
Color:
Gray
Size:
8.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Urinary antispasmodics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-6015
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5743 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)